Targeting each step of glutamine metabolism has shown promising results in cancer treatment, prompting the discovery of druggable targets and the development of anticancer drug candidates 3
Assessing the impact of GLP-1 RAs on cardiovascular and renal outcomes based on the presence or absence of chronic kidney disease (CKD) at baseline remains an important question in order to confirm whether their therapeutic effect is independent of kidney function
Obesity is now very common among patients with Crohns disease, yet there is limited guidance on how newer metabolic medications, particularly GLP-1 receptor agonists affect Crohns-related outcomes, presenting author Nakul Ganju, MD, an internal medicine resident at Howard University Hospital in Washington, DC, told GI & Hepatology News
TB-500 is een kort, lineair fragment dat specifiek het actine-bindend motief van thymosine 4 behoudt de LKKTET-sequentie die verantwoordelijk is voor de interactie met G-actine monomeren
Growth hormone is naturally released during deep sleep